Weekly roundup: May the ‘4th’ be with you! May the ‘4th’ be with you! (Sorry – we couldn’t help ourselves.) The force of innovation was strong across the life sciences sector this week. The Optimum team joined leaders from across the industry at this year’s BioEquity Europe conference in Prague, where discussions reflected the sector’s […]
With the Anglonordic Life Science Conference last week, BioEquity next week, ASGCT Annual meeting and LSX Nordic Congress around the corner, it is a good time to practice your pitching. Funds are open and now is the time to foster those new and old connections. Read on to discover what has happened this week and […]
Investment firms Jeito Capital raised a record $1.2 billion for Jeito II Fund to support clinical stage biopharma companies developing breakthrough therapies for diseases with high unmet medical needs Kurma Partners raised €215 million for Biofund IV to support the discovery and development of disruptive therapeutic solutions for severe or incurable diseases British Business Bank made a £100 million cornerstone commitment to Apposite Healthcare Growth Fund I to support innovative companies across medical products, diagnostics, life science tools, digital health and […]
Report outlines 17 targeted actions to address structural barriers hindering leadership progression Copenhagen / Oslo / Stockholm, April 17, 2026 — The Nordic life science sector is losing highly qualified female talent in top leadership positions, according to a new white paper published by Women in Life Science Denmark (WiLD), WiLD Norway, and VILDA Sweden. […]
Easter may be over, but momentum across life sciences is building. Anglonordic Life Science Conference is less than two weeks away, alongside a steady stream of clinical progress, partnerships, and industry milestones, it’s all go! Our latest Optimum TV episode features Stephen Hansen of BioCentury and offers fresh insights into market trends and the Q2 […]
